TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 68 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $130,000 | -64.3% | 270,300 | -0.4% | 0.00% | -100.0% |
| Q1 2019 | $364,000 | +45.6% | 271,500 | +22.9% | 0.00% | 0.0% |
| Q4 2018 | $250,000 | -38.4% | 221,000 | +50.2% | 0.00% | 0.0% |
| Q3 2018 | $406,000 | +222.2% | 147,100 | +699.5% | 0.00% | – |
| Q3 2017 | $126,000 | -35.7% | 18,400 | -33.1% | 0.00% | -100.0% |
| Q2 2017 | $196,000 | -68.9% | 27,500 | -59.9% | 0.00% | -50.0% |
| Q1 2017 | $630,000 | +221.4% | 68,600 | +41.2% | 0.00% | +100.0% |
| Q4 2016 | $196,000 | -1.0% | 48,600 | -6.0% | 0.00% | 0.0% |
| Q3 2016 | $198,000 | -50.5% | 51,700 | -44.4% | 0.00% | -50.0% |
| Q2 2016 | $400,000 | -15.8% | 93,000 | -9.3% | 0.00% | -33.3% |
| Q1 2016 | $475,000 | -36.4% | 102,500 | +37.6% | 0.00% | -25.0% |
| Q4 2015 | $747,000 | +17.3% | 74,500 | -12.8% | 0.00% | 0.0% |
| Q3 2015 | $637,000 | +103.5% | 85,400 | +1193.9% | 0.00% | +100.0% |
| Q2 2015 | $313,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 317,900 | $11,647,000 | 4.28% |
| Opaleye Management Inc. | 175,000 | $6,412,000 | 2.98% |
| Graticule Asia Macro Advisors LLC | 413,200 | $15,139,000 | 2.02% |
| BB BIOTECH AG | 1,477,114 | $54,121,000 | 1.61% |
| Iguana Healthcare Management, LLC | 75,000 | $2,748,000 | 1.16% |
| Granite Point Capital Management, L.P. | 79,250 | $2,904,000 | 1.06% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 458,202 | $16,788,000 | 0.89% |
| Ghost Tree Capital, LLC | 130,000 | $4,764,000 | 0.86% |
| SECTORAL ASSET MANAGEMENT INC | 605,393 | $22,182,000 | 0.84% |
| HealthCor Management, L.P. | 467,200 | $17,118,000 | 0.82% |